E-resources
Peer reviewed
Open access
-
Forgeard, Nathalie; Elessa, Dikélélé; Carpinteiro, Alexander; Belhadj, Karim; Minnema, Monique; Roussel, Murielle; Huart, Antoine; Javaugue, Vincent; Pascal, Laurent; Royer, Bruno; Talbot, Alexis; Gounot, Romain; Hegenbart, Ute; Schonland, Stefan; Karlin, Lionel; Harel, Stéphanie; Kastritis, Efstathios; Bridoux, Frank; Jaccard, Arnaud; Arnulf, Bertrand
Blood, 02/2024, Volume: 143, Issue: 8Journal Article
Teclistamab shows promising results in R/R AL amyloidosis, with VGPR or better in 88% of patients and involved FLC < 10 mg/L in 76%. We observed a 35% rate of severe infections and no cardiac or kidney related events.
